Reviva Pharmaceuticals Holdings, Inc. also files under TZAC, TZACU; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 18, 2026 | Bhat Laxminarayan | President and CEO, Director | Grant(A) | 109K | — | $0 |
| Mar 18, 2026 | Prabhu Narayan | Chief Financial Officer | Grant(A) | 41K | — | $0 |
| Mar 18, 2026 | Bhat Laxminarayan | President and CEO, Director | Grant(A) | 41K | — | $0 |
| Dec 18, 2025 | Funtleyder Leslie D. | Director | Grant(A) | 8K | — | $0 |
| Dec 18, 2025 | Saxena Parag | Director | Grant(A) | 8K | — | $0 |
| Dec 18, 2025 | Patel Purav | Director | Grant(A) | 8K | — | $0 |
| Dec 18, 2025 | Margolin Richard A | Director | Grant(A) | 8K | — | $0 |
| Feb 13, 2025 | Bhat Laxminarayan | President and CEO, Director, 10% Owner | Grant(A) | 182K | — | $0 |
| Feb 13, 2025 | Bhat Laxminarayan | President and CEO, Director, 10% Owner | Grant(A) | 519K | — | $0 |
| Feb 13, 2025 | Narayan Prabhu | Chief Financial Officer | Grant(A) | 194K | — | $0 |
| Dec 10, 2024 | Margolin Richard A | Director | Grant(A) | 8K | — | $0 |
| Dec 10, 2024 | Funtleyder Leslie D. | Director | Grant(A) | 8K | — | $0 |
| Dec 10, 2024 | Saxena Parag | Director, 10% Owner | Grant(A) | 8K | — | $0 |
| Dec 10, 2024 | Patel Purav | Director | Grant(A) | 8K | — | $0 |
| Sep 15, 2024 | Narayan Prabhu | Chief Financial Officer | Grant(A) | 97K | — | $0 |
| Sep 15, 2024 | Bhat Laxminarayan | President and CEO, Director, 10% Owner | Grant(A) | 158K | — | $0 |
| Sep 15, 2024 | Bhat Laxminarayan | President and CEO, Director, 10% Owner | Grant(A) | 78K | — | $0 |
| Nov 20, 2023 | Vedanta Partners, LLC | 10% Owner | Other(J) | 585K | — | — |
| Nov 20, 2023 | Vedanta Partners, LLC | 10% Owner | Other(J) | 585K | — | — |
| Nov 13, 2023 | Saxena Parag | Director, 10% Owner | Grant(A) | 8K | — | $0 |
| Nov 13, 2023 | Patel Purav | Director | Grant(A) | 8K | — | $0 |
| Nov 13, 2023 | Margolin Richard A | Director | Grant(A) | 8K | — | $0 |
| Nov 13, 2023 | Funtleyder Leslie D. | Director | Grant(A) | 8K | — | $0 |
| Apr 25, 2023 | Bhat Laxminarayan | President and CEO, Director, 10% Owner | Grant(A) | 150K | — | $0 |
| Apr 25, 2023 | Bhat Laxminarayan | President and CEO, Director, 10% Owner | Grant(A) | 443K | — | $0 |
| Apr 25, 2023 | Narayan Prabhu | Chief Financial Officer | Grant(A) | 170K | — | $0 |
| Nov 18, 2022 | Patel Purav | Director | Buy(P) | 3K | $4.69 | $14K |
| Nov 10, 2022 | Funtleyder Leslie D. | Director | Grant(A) | 4K | — | $0 |
| Nov 10, 2022 | Margolin Richard A | Director | Grant(A) | 4K | — | $0 |
| Nov 10, 2022 | Patel Purav | Director | Grant(A) | 4K | — | $0 |
| Nov 10, 2022 | Saxena Parag | Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Sep 30, 2022 | Narayan Prabhu | Chief Financial Officer | Buy(P) | 50K | $1.66 | $83K |
| Sep 8, 2022 | Vedanta Associates, L.P. | 10% Owner | Buy(P) | 514K | — | $0 |
| Sep 8, 2022 | Vedanta Associates, L.P. | 10% Owner | Buy(P) | 870K | — | $0 |
| Sep 8, 2022 | Vedanta Associates, L.P. | 10% Owner | Buy(P) | 514K | $2.53 | $1.3M |
| Sep 8, 2022 | Vedanta Associates, L.P. | 10% Owner | Buy(P) | 870K | $2.53 | $2.2M |
| Jun 30, 2022 | Narayan Prabhu | Chief Financial Officer | Buy(P) | 50K | $1.21 | $61K |
| Dec 8, 2021 | Saxena Parag | Director, 10% Owner | Grant(A) | 5K | — | $0 |
| Dec 8, 2021 | Funtleyder Leslie D. | Director | Grant(A) | 5K | — | $0 |
| Dec 8, 2021 | Margolin Richard A | Director | Grant(A) | 5K | — | $0 |
| Dec 8, 2021 | Patel Purav | Director | Grant(A) | 5K | — | $0 |
| Jun 15, 2021 | Saxena Parag | Director, 10% Owner | Grant(A) | 4K | — | $0 |
| Jun 15, 2021 | Funtleyder Leslie D. | Director | Grant(A) | 4K | — | $0 |
| Jun 15, 2021 | Margolin Richard A | Director | Grant(A) | 4K | — | $0 |
| Jun 15, 2021 | Patel Purav | Director | Grant(A) | 4K | — | $0 |
| Jun 1, 2021 | Vedanta Associates-R, LP | 10% Owner | Buy(P) | 931K | $3.75 | $3.5M |
| Jun 1, 2021 | Vedanta Associates-R, LP | 10% Owner | Buy(P) | 399K | $3.75 | $1.5M |
| Jun 1, 2021 | Vedanta Associates-R, LP | 10% Owner | Buy(P) | 931K | — | — |
| Jun 1, 2021 | Vedanta Associates-R, LP | 10% Owner | Buy(P) | 399K | — | — |
| Apr 14, 2021 | Narayan Prabhu | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| Apr 14, 2021 | Patel Purav | Director | Grant(A) | 15K | — | $0 |
| Dec 15, 2020 | Saxena Parag | Director, 10% Owner | Other(J) | 541K | — | — |
| Dec 14, 2020 | Saxena Parag | Director, 10% Owner | Grant(A) | 198K | — | — |
| Dec 14, 2020 | Saxena Parag | Director, 10% Owner | Other(J) | 343K | — | — |
| Dec 14, 2020 | Saxena Parag | Director, 10% Owner | Grant(A) | 198K | — | — |
| Dec 8, 2020 | Glazer Capital, LLC | 10% Owner | Sell(S) | 367K | $10.88 | $4.0M |
| Dec 8, 2020 | Gerber Sander | 10% Owner | Other(J) | 710K | $10.88 | $7.7M |
| Dec 7, 2020 | Gerber Sander | 10% Owner | Sell(S) | 50K | $11.51 | $576K |
| Dec 3, 2020 | Glazer Capital, LLC | 10% Owner | Other(J) | 606K | $10.88 | $6.6M |
| Dec 2, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 261 | $11.00 | $3K |
| Dec 1, 2020 | Glazer Capital, LLC | 10% Owner | Sell(S) | 5K | $11.00 | $59K |
| Nov 27, 2020 | Glazer Capital, LLC | 10% Owner | Sell(S) | 6K | $10.90 | $65K |
| Nov 24, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 7K | $10.90 | $77K |
| Nov 23, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 24K | $10.90 | $257K |
| Nov 18, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 896 | $10.90 | $10K |
| Nov 17, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 127 | $10.90 | $1K |
| Nov 16, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 305 | $10.90 | $3K |
| Nov 11, 2020 | Glazer Capital, LLC | 10% Owner | Sell(S) | 5 | $10.90 | $55 |
| Nov 6, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 1 | $10.90 | $11 |
| Nov 3, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 58K | $10.85 | $625K |
| Nov 2, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 1 | $11.50 | $12 |
| Nov 2, 2020 | Gerber Sander | 10% Owner | Sell(S) | 50K | $10.87 | $544K |
| Sep 29, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 2 | $11.50 | $23 |
| Sep 17, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 1K | $10.80 | $11K |
| Sep 14, 2020 | Glazer Paul J | 10% Owner | Sell(S) | 1 | $10.80 | $11 |
| May 8, 2020 | Mizuho Securities USA LLC | 10% Owner | Sell(S) | 51K | $10.62 | $542K |
| Mar 20, 2020 | Gerber Sander | 10% Owner | Buy(P) | 10K | $10.37 | $104K |
| Aug 30, 2018 | Nayar Rahul | Chief Executive Officer, Director, 10% Owner | Buy(P) | 33K | $10.00 | $330K |
| Aug 30, 2018 | Saxena Parag | Chairman of the Board, Director, 10% Owner | Buy(P) | 33K | $10.00 | $330K |
| Aug 30, 2018 | Tenzing LLC | 10% Owner | Buy(P) | 33K | $10.00 | $330K |
| Aug 23, 2018 | Saxena Parag | Chairman of the Board, Director, 10% Owner | Buy(P) | 310K | $10.00 | $3.1M |
| Aug 23, 2018 | Nayar Rahul | Chief Executive Officer, Director, 10% Owner | Buy(P) | 310K | $10.00 | $3.1M |
| Aug 23, 2018 | Tenzing LLC | 10% Owner | Buy(P) | 310K | $10.00 | $3.1M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Reviva Pharmaceuticals Holdings, Inc., SEC CIK 0001742927. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under RVPH and shows every filing by that issuer (also filed as TZAC, TZACU).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for RVPH